What is the address of DRS SERETAN-IVANOIU MEDECINE GENERALE?

The registered office of DRS SERETAN-IVANOIU MEDECINE GENERALE is located at Chemin des Ajoncs(WP) 10, 5100 Namur.

Is DRS SERETAN-IVANOIU MEDECINE GENERALE still active?

Yes. According to the CBE (1 October 2026) DRS SERETAN-IVANOIU MEDECINE GENERALE is active, legal situation “Normale toestand”, started on 13 April 2018.

Is DRS SERETAN-IVANOIU MEDECINE GENERALE registered on Peppol?

No, DRS SERETAN-IVANOIU MEDECINE GENERALE is currently not registered on the Peppol network.

What is the enterprise number of DRS SERETAN-IVANOIU MEDECINE GENERALE?

The enterprise number of DRS SERETAN-IVANOIU MEDECINE GENERALE is BE0694744484.

When was DRS SERETAN-IVANOIU MEDECINE GENERALE founded?

DRS SERETAN-IVANOIU MEDECINE GENERALE was founded on 13 April 2018.

Who are the directors of DRS SERETAN-IVANOIU MEDECINE GENERALE?

According to the 2025 annual accounts, the directors of DRS SERETAN-IVANOIU MEDECINE GENERALE are: Mirela SERETAN, Toma IVANOIU.

Is DRS SERETAN-IVANOIU MEDECINE GENERALE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 13 April 2018; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did DRS SERETAN-IVANOIU MEDECINE GENERALE make in 2025?

DRS SERETAN-IVANOIU MEDECINE GENERALE posted a profit after taxes of € 11,660 in financial year 2025.

What is the revenue of DRS SERETAN-IVANOIU MEDECINE GENERALE?

As a small company, DRS SERETAN-IVANOIU MEDECINE GENERALE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 38,114.

DRS SERETAN-IVANOIU MEDECINE GENERALE (Private Limited)

Dossier DRS SERETAN-IVANOIU MEDECINE GENERALE, printed on 1 October 2026 from databakkes.be/en/0694744484/drs-seretan-ivanoiu-medecine-generale. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

DRS SERETAN-IVANOIU MEDECINE GENERALE from Namur, company number BE0694744484, closed financial year 2025 with a result of € 11,660 after tax. For that financial year DRS SERETAN-IVANOIU MEDECINE GENERALE recorded a gross margin of € 38,114 and equity of € 90,029. Compared with financial year 2024, the result moved from € 1,509 to € 11,660. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 27, 2026.

What it is worth Healthy

€ 90,029

▼ 30% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 11,660

▲ € 10,150 vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 9,387

▼ 74% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 50,000 paid out

More than the year’s profit went to the shareholders; reserves fell.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 6,082

▼ 10% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 3,884

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 32,297 Gross margin 2022: € 32,297 First fiscal year in the series	€ 31,319 Gross margin 2023: € 31,319 ▼ 3% vs 2022 (€ 32,297) Unfavourable step	€ 24,908 Gross margin 2024: € 24,908 ▼ 20% vs 2023 (€ 31,319) Unfavourable step	€ 38,114 Gross margin 2025: € 38,114 ▲ 53% vs 2024 (€ 24,908) Favourable step	▲ 53%
Profit after taxes	€ 5,236 Profit after taxes 2022: € 5,236 First fiscal year in the series	€ 6,587 Profit after taxes 2023: € 6,587 ▲ 26% vs 2022 (€ 5,236) Favourable step	€ 1,509 Profit after taxes 2024: € 1,509 ▼ 77% vs 2023 (€ 6,587) Unfavourable step	€ 11,660 Profit after taxes 2025: € 11,660 ▲ € 10,150 vs 2024 (€ 1,509) Favourable step	▲ € 10,150
Equity	€ 130,274 Equity 2022: € 130,274 First fiscal year in the series	€ 136,861 Equity 2023: € 136,861 ▲ 5% vs 2022 (€ 130,274) Favourable step	€ 128,370 Equity 2024: € 128,370 ▼ 6% vs 2023 (€ 136,861) Unfavourable step	€ 90,029 Equity 2025: € 90,029 ▼ 30% vs 2024 (€ 128,370) Unfavourable step	▼ 30%
Total debts	€ 28,885 Total debts 2022: € 28,885 First fiscal year in the series	€ 19,344 Total debts 2023: € 19,344 ▼ 33% vs 2022 (€ 28,885) Favourable step	€ 16,309 Total debts 2024: € 16,309 ▼ 16% vs 2023 (€ 19,344) Favourable step	€ 9,966 Total debts 2025: € 9,966 ▼ 39% vs 2024 (€ 16,309) Favourable step	▼ 39%
Cash	€ 57,809 Cash 2022: € 57,809 First fiscal year in the series	€ 12,905 Cash 2023: € 12,905 ▼ 78% vs 2022 (€ 57,809) Unfavourable step	€ 36,105 Cash 2024: € 36,105 ▲ 180% vs 2023 (€ 12,905) Favourable step	€ 9,387 Cash 2025: € 9,387 ▼ 74% vs 2024 (€ 36,105) Unfavourable step	▼ 74%
Land & buildings	€ 2,556 Land & buildings 2022: € 2,556 First fiscal year in the series	€ 41,339 Land & buildings 2023: € 41,339 ▲ € 38,783 vs 2022 (€ 2,556) Unchanged	€ 41,894 Land & buildings 2024: € 41,894 ▲ 1% vs 2023 (€ 41,339) Unchanged	€ 42,082 Land & buildings 2025: € 42,082 Unchanged (€ 41,894) Unchanged
Retained profit	€ 111,674 Retained profit 2022: € 111,674 First fiscal year in the series	€ 118,261 Retained profit 2023: € 118,261 ▲ 6% vs 2022 (€ 111,674) Favourable step	€ 109,770 Retained profit 2024: € 109,770 ▼ 7% vs 2023 (€ 118,261) Unfavourable step	€ 71,429 Retained profit 2025: € 71,429 ▼ 35% vs 2024 (€ 109,770) Unfavourable step	▼ 35%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 10,000 Dividend 2024: € 10,000 Unchanged (€ 0) Unchanged	€ 50,000 Dividend 2025: € 50,000 ▲ € 40,000 vs 2024 (€ 10,000) Unchanged	▲ € 40,000
Balance sheet total	€ 159,159 Balance sheet total 2022: € 159,159 First fiscal year in the series	€ 156,205 Balance sheet total 2023: € 156,205 ▼ 2% vs 2022 (€ 159,159) Unchanged	€ 144,678 Balance sheet total 2024: € 144,678 ▼ 7% vs 2023 (€ 156,205) Unchanged	€ 99,995 Balance sheet total 2025: € 99,995 ▼ 31% vs 2024 (€ 144,678) Unchanged	▼ 31%

Key figures of DRS SERETAN-IVANOIU MEDECINE GENERALE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DRS SERETAN-IVANOIU MEDECINE GENERALE?

What happened at DRS SERETAN-IVANOIU MEDECINE GENERALE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 27, 2026 New annual accounts for financial year 2025: profit of € 11,660 (▲ € 10,150 vs 2024). filed late Source: NBB ↗
Apr 13, 2018 New establishment in Namur. KBO
Apr 13, 2018 Start of the company according to the CBE. KBO

In short

From € 5,236 profit in 2022 to € 11,660 profit in 2025.

Paid € 10,104 in corporate taxes since 2022.

Best year ever: 2025, with € 11,660 profit.

Paid out € 60,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DRS SERETAN-IVANOIU MEDECINE GENERALE? We notify you, reason included.

Follow DRS SERETAN-IVANOIU MEDECINE GENERALE

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Mirela SERETAN Toma IVANOIU

DRS SERETAN-IVANOIU MEDECINE GENERALE

Behind DRS SERETAN-IVANOIU MEDECINE GENERALE are Mirela SERETAN and Toma IVANOIU.

See the full network in the app

Directors

According to the 2025 annual accounts

Mirela SERETAN

Director

Toma IVANOIU

Autre fonction

Establishments

Establishment units

Physical locations of this company

Registered office

Chemin des Ajoncs(WP) 10

5100 Namur

2.275.442.628

Avenue du Val Saint-Georges 11

5000 Namur

Active since 13 April 2018

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0694.744.484
VAT number: BE 0694.744.484
Registered office: Chemin des Ajoncs(WP) 10, 5100 Namur
Names & denominations: DRS SERETAN-IVANOIU MEDECINE GENERALE · DRS SERETAN-IVANOIU M.G.
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 13 April 2018
Peppol: Not registered

View on CBE Public ↗ Annual accounts (NBB) ↗